Previous 10 |
Smith & Nephew plc (NYSE: SNN ) had declared $0.27/share semi-annual dividend . More news on: Smith & Nephew plc, Dividend News, Read more ...
Medical device makers may experience some mild pressure today on the heels of the re-release by Netflix of " The Bleeding Edge ," a documentary critical of the device industry. Specific products highlighted are Bayer's ( OTCPK:BAYRY ) Essure contraceptive device and Intuitive Surgical's (NAS...
It’s difficult to find much comfort with Stryker ’s ( SYK ) valuation, but the company continues to deliver exceptional financial results that at least help kick the valuation can a little further down the road. MAKO continues to drive share growth from Stryker in knee implants,...
Smith & Nephew Plc (SNN) Q2 2018 Results Earnings Conference Call July 26, 2018 04:00 AM ET Executives Namal Nawana - CEO Ian Melling - SVP, Group Finance Phil Cowdy - Head, Business Development and Corporate Affairs Analysts Lisa Clive - Sanford Bernstein Michael Jun...
The following slide deck was published by Smith & Nephew plc in conjunction with their 2018 Q2 earnings Read more ...
Smith & Nephew plc (NYSE: SNN ): 1H EPS of $0.44 More news on: Smith & Nephew plc, Earnings news and commentary, Stocks on the move, Healthcare stocks news, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Smith & Nephew SNATS Inc. Company Name:
SNN Stock Symbol:
NYSE Market:
Smith & Nephew SNATS Inc. Website:
Engineered for precision, confidence and efficiency in surgery - and compatible with the CORI ◊ Surgical System Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has received 510(k) clearance for its new CATALYSTEM Primary Hip System fro...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company announces its Orthopaedics for All initiative – a global advisory board established to amplify diversity by building equity, breaking biases, and inspiring inclusion for individuals wishing to pursue a career in ort...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it will sponsor tennis players participating in The Championships, Wimbledon 2024 to spotlight its advanced Sports Medicine portfolio alongside some of the greatest athletes in the world. Smith+Nephew endeavou...